Immediate Impact

1 from Science/Nature 82 standout
Sub-graph 1 of 21

Citing Papers

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
2022 Standout
1 intermediate paper

Works of Phillippa Poole being referenced

Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease
2020
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
2017

Author Peers

Author Last Decade Papers Cites
Phillippa Poole 2283 482 464 1261 105 3.5k
Charles L. Emerman 1800 206 461 878 136 5.6k
Christopher G. Slatore 2639 118 831 374 175 5.1k
Brydon J. B. Grant 2815 532 425 1683 91 5.9k
C. M. Fletcher 4297 430 539 2277 89 6.3k
André Gervais 910 80 435 1127 72 2.5k
Marc J. Shapiro 576 629 514 762 131 4.8k
Jean‐Paul Collet 1370 416 837 563 127 5.7k
Sunday Clark 1557 214 586 2044 208 6.3k
Anne L. Fuhlbrigge 2881 237 258 3734 111 5.1k
Matthew M. Hutter 1003 432 383 828 100 5.5k

All Works

Loading papers...

Rankless by CCL
2026